Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term statins for ischemia-reperfusion injury
NCT00987974Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2009
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, atorvastatin in ischemia-reperfusion injury (IRI), endothelial dysfunction, sponsored by Radboud University Medical Center. Started Sep 2009; status: completed.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
ischemia-reperfusion injury (IRI)endothelial dysfunction
Beyond the preview
Go deeper on NCT00987974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987974.